Evidence map›Paper›PMID 40076249›Full record

ArticleMolecules (Basel, Switzerland)2025

Diverse Structures of Tea Polyphenols from Rougui Wuyi Rock Tea and Their Potential as Inhibitor of 3C-like Protease.

Qing Sun, Xiaojuan Chen, Jie Zhang, Juan Song, Lan Yao, Yang Zhao, Guang Yang, Xiu Wang, Haizhen Liang, Baiping Ma

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qing SunBeijing Institute of Radiation Medicine, Beijing 100850, China.
Xiaojuan ChenBeijing Institute of Radiation Medicine, Beijing 100850, China.ORCID 0009-0008-3079-8507
Jie ZhangBeijing Institute of Radiation Medicine, Beijing 100850, China.
Juan SongBeijing Institute of Radiation Medicine, Beijing 100850, China.
Lan YaoBeijing Institute of Radiation Medicine, Beijing 100850, China.
Yang ZhaoBeijing Institute of Radiation Medicine, Beijing 100850, China.ORCID 0000-0002-2082-4248
Guang YangBeijing Institute of Radiation Medicine, Beijing 100850, China.
Xiu WangBeijing Institute of Radiation Medicine, Beijing 100850, China.
Haizhen LiangBeijing Institute of Radiation Medicine, Beijing 100850, China.
Baiping MaBeijing Institute of Radiation Medicine, Beijing 100850, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tea polyphenols, the primary bioactive constituents responsible for the various health benefits of tea, can be categorized into different subgroups according to their structural characteristics. However, the distinctions in antiviral activity among the diverse types of polyphenolic compounds remain unexplored. In the present study, fifty-eight tea polyphenols with varied structures, including eleven undescribed compounds, were isolated from Rougui Wuyi rock tea. Their molecular structures were elucidated using comprehensive analytical approaches of NMR, HRMS, CD spectroscopic data and acid hydrolysis. The isolated polyphenol analogs could be structurally classified into two main categories: flavan-3-ols, which include catechins, flavoalkaloids, procyanidins and theasinensins, and flavones, encompassing kaempferol, quercetin, myricetin, and their respective glycosides. The inhibitory activities of fifty-eight tea polyphenols against 3CLpro were assessed in vitro, and eighteen phenolic compounds exhibited inhibitory effects on 3CLpro, with IC

Indexed as

Coronavirus 3C ProteasesPolyphenolsProtease InhibitorsTeaAntiviral AgentsFlavonoidsMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAntiviral AgentsCoronavirus 3C ProteasesFlavonoidsPolyphenolsProtease InhibitorsTea3CLproantiviralRougui Wuyi Rock teatea polyphenols

Identifiers

PMID40076249
PMCPMC11901911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.